The WHO is suspending a large clinical trial of hydroxychloroquine, citing a report linking the drug to higher death rates in COVID-19 patients. President Trump has advocated its use during the pandemic despite limited research on its effectiveness.
A pharmacy tech pours out pills of hydroxychloroquine May 20 at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. After a study found COVID-19 patients using the drug were dying at higher rates, the World Health Organization announced it would suspend its clinical trial.A pharmacy tech pours out pills of hydroxychloroquine May 20 at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020.
The WHO's chief scientist, Soumya Swaminathan, says the review was prompted by the article in The Lancet, which was not a randomized control trial but still large. "The steering committee met over the weekend, in the light of this uncertainty," Swaminathan says."We decided we should be proactive, err on the side of caution and suspend enrollment temporarily into the hydroxychloroquine arm [of the Solidarity trial]."
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WHO temporarily halts trial of hydroxychloroquine over safety concernsThe group wants to 'be proactive, err on the side of caution' when it comes to the malaria drug's use in treating COVID-19.
Read more »
WHO temporarily halts trial of hydroxychloroquine over safety concernsThe World Health Organization announced on Monday that it's suspending a trial of hydroxychloroquine in treating COVID-19, saying fears of the drug's potential danger is causing it to 'err on the side of caution'
Read more »
WHO temporarily halts trial of hydroxychloroquine over safety concernsThe group wants to 'be proactive, err on the side of caution' when it comes to the malaria drug's use in treating COVID-19.
Read more »
WHO pauses trial of hydroxychloroquine as coronavirus treatment amid safety concernsHydroxychloroquine, which Trump has repeatedly touted as a potential game changer in fighting the coronavirus, is an anti-malarial drug that's also used by doctors to treat rheumatoid arthritis and lupus.
Read more »
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concernsThe World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
Read more »
WHO pauses hydroxychloroquine trial amid safety concerns day after Trump says he stopped taking controversial medicineThe trial pause comes the day after the president revealed he was no longer taking the unproven coronavirus treatment and prevention method that health experts and officials—including within the Trump administration—have warned not to use.
Read more »